CELL BIOLOGY, GENETICS, AND BIOCHEMISTRY OF GIARDIA
Project Number5R01AI048082-05
Contact PI/Project LeaderSAMUELSON, JOHN C.
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Giardia lamblia is an amitochondriate, binucleate protist that causes diarrhea in the US and the
developing world. Our preliminary results make numerous important contributions to the understanding of
the cell biology, genetics, and biochemistry of G. iamblia.
Cell biology: Nuclear membranes remain intact during cell division. Giardia divide with mirror-image
symmetry in the plane of the adherence disc. Pairs of nuclei of dividing giardia are tethered together by
arrays of microtubules. The giardia [2Fe-2S] ferredoxin has an organelle-targeting sequence.
Genetics: The GS strain, which was used to prove Koch's postulates, has symmetric nuclei that are each
diploid. The WB strain, which is presently being sequenced, has asymmetric nuclei that are a mixture of
monosomic and trisomic chromosomes. Four copies of each giardia gene all have the same sequence.
Giardia lack most of the machinery for sex. Giardia have a spliceosomal intron.
Biochemistry: Genes encoding the majority of giardia fermentation enzymes were laterally transferred
from anaerobic prokaryotes. Giardia contain genes encoding nitroreductases, which are similar to those
that activate metronidazole in bacteria. Giardia have an Fe-hydrogenase. These results suggest multiple
hypotheses that will be tested in three Specific Aims.
Major hypothesis for Aim 1 (cell biology): Perinuclear microtubules tether together pairs of nuclei of
dividing giardia, so nuclei are correctly distributed to mother and daughter giardia.
Major hypotheses for Aim 2 (genetics): Giardia are tetraploid but sequence like haploids; symmetric
diplomonad nuclei are diploid for each chromosome (like GS); while asymmetric diplomonad nuclei have
a mixture of monosomic and trisomic chromosomes (like WB). Minor hypothesis: Giardia are capable of
splicing heterologous introns.
Major hypothesis for Aim 3 (biochemistry): Giardia is sensitive to metronidazole and furazolidone,
because of the presence of nitroreductases, like those of anaerobic bacteria, which reduce and activate
these drugs.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
15-February-2003
Project End Date
31-January-2009
Budget Start Date
01-February-2007
Budget End Date
31-January-2009
Project Funding Information for 2007
Total Funding
$344,546
Direct Costs
$213,341
Indirect Costs
$131,205
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Allergy and Infectious Diseases
$344,546
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI048082-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI048082-05
Patents
No Patents information available for 5R01AI048082-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI048082-05
Clinical Studies
No Clinical Studies information available for 5R01AI048082-05
News and More
Related News Releases
No news release information available for 5R01AI048082-05
History
No Historical information available for 5R01AI048082-05
Similar Projects
No Similar Projects information available for 5R01AI048082-05